CD8A and neoplasm: In conclusion, we performed TCR sequencing and IOCT analysis on anti-CD4 mAb treated tumor-bearing mice and demonstrated that anti-CD4 mAb treatment enhanced the expansion of a wide variety of CD8+ T cell clones in the dLN and their translocation to the tumor.